Daily Financial Update
Market Pulse: Federal drug approvals have ignited biotech optimism, lifting sector vibes despite mixed earnings elsewhere.
Key Movers: Rhythm Pharmaceuticals, Denali Therapeutics and LivaNova grabbed headlines with regulatory greenlights and clinical milestones.
Macro & Politics: Claims of suppressed Alzheimer’s cures from “The Great Alzheimer’s Scam” narrative collide with official approval pipelines, stoking skepticism.
What’s Next: Watch biotech valuations and M&A chatter once trading kicks off.
Market Commentary
Everyone’s overlooking how the frenzy around recent FDA nods—from Denali Therapeutics’ AVLAYAH approval (GlobeNewswire) to Rhythm Pharmaceuticals’ CHMP win (GlobeNewswire)—could backfire if broader profit expectations evaporate. Investors are piling in expecting big M&A, but the cash burn on noninvasive neurostimulation from BrainsWay’s Proliv™Rx system (GlobeNewswire) reminds us that pipeline promises aren’t guaranteed payoffs. That’s a misread that could get some traders burned.
It’s odd that crypto setups in “XRP Could Be Building A Major Short Squeeze, Analyst Says” (newsBTC) and Charles Hoskinson’s call to plug Cardano into real use cases (ZyCrypto) rarely get woven into the biotech boom narrative. But here’s the thesis: if retail funds pivot from expected crypto rallies into hot biotechs, markets could see sudden reversals on both fronts. Cross-asset flows matter more than sector headlines.
Don’t wait for consensus to catch up. Position around catalysts—consider trimming positions ahead of European decisions on IMCIVREE (GlobeNewswire) and zooming into ADA or XRP only once you spot genuine short-covering momentum. The play: ride the squeeze, but lock in gains when the story shifts.
📈 Breaking Financial News
BrainsWay Completes Additional $6 Million Milestone-Based Investment in Neurolief Ltd. Following FDA Approval of Proliv™Rx System for MDD
BURLINGTON, Mass. and JERUSALEM, March 26, 2026 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced the compl…
Kamada Announces FDA Approval of its Plasma Collection Center in San Antonio, Texas
REHOVOT, Israel and HOBOKEN, N.J., March 26, 2026 (GLOBE NEWSWIRE) — Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty p…
LivaNova (LIVN) Announces FDA Approval of aura6000 System for Obstructive Sleep Apnea
LivaNova PLC (NASDAQ:LIVN) is one of the 12 Best UK Stocks to Buy According to Hedge Funds. On March 19, 2026, LivaNova PLC (NASDAQ:LIVN) announced that the …
Denali Therapeutics granted FDA approval of AVLAYAH for treatment of MPS II
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual investors, professional money managers, active traders, and corpor…
Denali Therapeutics Announces U.S. FDA Approval of AVLAYAH™ (tividenofusp alfa-eknm) for Treatment of Hunter Syndrome (MPS II)
SOUTH SAN FRANCISCO, Calif., March 25, 2026 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (Nasdaq: DNLI) today announced the U.S. Food and Drug Administration (FDA) has granted accelerated approval for AVLAYAH™ (tividenofusp alfa-eknm), the first FDA-approved …
The Cross-Chain Giant Set for 1,000%+ Gains As crypto markets surge post-tariffs
Its transaction volume is skyrocketing across all major blockchains while its price remains suppressed as retail has yet to discover it – creating a coiled spring ready to release. Breaking: Access our urgent research on this cross-chain opportunity for just $3!
🔍 Market Analysis & Insights
XRP Could Be Building A Major Short Squeeze, Analyst Says
XRP may be setting up for a large upside liquidation event even as price action remains fragile in the short term, according to Cryptoinsightuk analyst Will Taylor, who argued in a March 24 video that leverage positioning, funding data, and broader market str…
Gelatine Sculpt Claims Evaluated: Documenting the Gelatin Trick Recipe Investigation for Consumer Safety
Gelatine Sculpt gelatin trick recipe claims, bariatric jelly terminology, GLP-1 marketing references, ingredient disclosure, and label verification….
Vivani Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Successful completion of first-in-human study LIBERATE-1 paired with preclinical proof of concept data for a semaglutide implant advance NPM-139, miniature, ultra long-acting semaglutide implant under development for chronic weight management toward a Phase 1…
GameStop (GME) Stock Holds Steady Near $23 After Mixed Q4 Earnings, Cash Pile Grows
GameStop Corp. shares traded modestly lower in early Thursday trading as investors digested the video game retailer's latest quarterly results, which showed declining revenue amid a broader industry shift to digital downloads but a surge in profitability and …
Rhythm Pharmaceuticals Receives Positive CHMP Opinion for IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients with Acquired Hypothalamic Obesity due to Hypothalamic Injury or Impairment
— European Commission decision anticipated in second quarter of 2026 — BOSTON, March 26, 2026 (GLOBE NEWSWIRE) — Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients …
Wall St Legend: AGI Arrives Q1 2026. The Power Grab Started Months Ago. While retail buys Nvidia at all-time highs, institutions position into something else. Why? AI needs POWER. Louis Navellier, who spent 46 yrs Wall St. and called Nvidia at $1, reveals that his grading system shows where the money is REALLY flowing. Companies you've never heard of. Stocks the media never covers. Before Stage 3 begins… Click here for the full story.
Click here for the full story.
💰 Investment Opportunities
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarter…
Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update
TORONTO, March 26, 2026 (GLOBE NEWSWIRE) — Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced its financial results for the fourth quarte…
Charles Hoskinson Makes Simple But Powerful Request to Cardano Users
Cardano founder Charles Hoskinson is issuing a direct call to action for the network’s users: put the chain to work and make it stronger.
Originally published on ZyCrypto – blockchain news, expert analysis, and Web3 coverage.
Full article at ZyCrypto.com
The Great Alzheimer’s Scam and the Proven Cures They’ve Buried for Billions
A New Series of Health Insights Is on the Way
IMPORTANT
A New Series of Health Insights Is on the Way
Our team has been working behind the scenes to prepare new research and practical health strategies for our readers. While we finish preparing wha…
Cardano ADA shorts spike to highest since June 2023 as 71% crash meets Midnight launch this week risk
Cardano is attempting to turn the imminent mainnet launch of the Midnight network, a privacy-focused sidechain, into a repair job as market data signals extreme negative sentiment toward its native ADA token. Data from Santiment shows that the average wallet …
White House Insider Buck Sexton: “Trump's Next Move Will Shock the World” It cou
dramatically increase U.S. power… and trigger a massive American market boom the likes of which we haven't seen in 75 years. Get the details here now.